Transaction in Own Shares

Summary by AI BETAClose X

On October 22, 2025, GSK plc, acting through BNP Paribas SA, purchased 248,000 of its own ordinary shares, each with a nominal value of 31¼ pence. The shares were bought at prices ranging from 1,625.00p to 1,655.00p per share, with a volume-weighted average price of 1,644.38p per share. These shares will be held as treasury shares as part of the company's existing buyback program, which was initially announced on September 30, 2025. Since then, GSK has purchased 5,361,500 ordinary shares. Following this transaction, GSK holds 252,826,344 ordinary shares in treasury and has 4,062,590,575 ordinary shares in issue, excluding treasury shares. The percentage of voting rights attributable to ordinary shares held in treasury is 6.22 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings